Literature DB >> 27590452

Valvular heart disease in older adults: seeking an ounce of prevention.

Amil M Shah1, Scott D Solomon2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27590452      PMCID: PMC5216200          DOI: 10.1093/eurheartj/ehw354

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  23 in total

1.  Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study).

Authors:  E C Jones; R B Devereux; M J Roman; J E Liu; D Fishman; E T Lee; T K Welty; R R Fabsitz; B V Howard
Journal:  Am J Cardiol       Date:  2001-02-01       Impact factor: 2.778

2.  Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study.

Authors:  N E Lebowitz; J N Bella; M J Roman; J E Liu; D P Fishman; M Paranicas; E T Lee; R R Fabsitz; T K Welty; B V Howard; R B Devereux
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

3.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

4.  First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve.

Authors:  Joachim Schofer; Klaudija Bijuklic; Claudia Tiburtius; Lorenz Hansen; Adam Groothuis; Rebecca T Hahn
Journal:  J Am Coll Cardiol       Date:  2015-03-04       Impact factor: 24.094

5.  Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)

Authors:  J P Singh; J C Evans; D Levy; M G Larson; L A Freed; D L Fuller; B Lehman; E J Benjamin
Journal:  Am J Cardiol       Date:  1999-03-15       Impact factor: 2.778

6.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.

Authors:  S Joanna Cowell; David E Newby; Robin J Prescott; Peter Bloomfield; John Reid; David B Northridge; Nicholas A Boon
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

7.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Authors:  Anne B Rossebø; Terje R Pedersen; Kurt Boman; Philippe Brudi; John B Chambers; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf; Ingar Holme; Y Antero Kesäniemi; William Malbecq; Christoph A Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Journal:  N Engl J Med       Date:  2008-09-02       Impact factor: 91.245

8.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.

Authors:  K D O'Brien; D D Reichenbach; S M Marcovina; J Kuusisto; C E Alpers; C M Otto
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-04       Impact factor: 8.311

9.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

10.  Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

Authors:  Kwan Leung Chan; Koon Teo; Jean G Dumesnil; Andy Ni; James Tam
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.